Opens in a new tab

Financial Calendar 2026



10/02/2026


Board of Directors

Meeting of the Board of Directors for the approval of the 2025 annual turnover not subject to audit



27/03/2026


Board of Directors

Board of Directors meeting to approve the draft financial statements as of December 31, 2025



29/04/2026


Shareholders' Meeting

First call for the Shareholders’ meeting to approve the financial statements as of December 31, 2025



30/04/2026


Shareholders' Meeting

Second call for the Shareholders’ meeting to approve the financial statements as of December 31, 2025



06/05/2026


Board of Directors

Meeting of the Board of Directors for the approval of the turnover as of 31 March 2026 not subject to audit



14/07/2026


Board of Directors

Meeting of the Board of Directors for the approval of the turnover as of 30 June 2026 not subject to audit



29/09/2026


Board of Directors

Board of Directors meeting to approve the semi-annual report as of June 30, 2026 voluntarily subjected to audit



05/11/2026


Board of Directors

Meeting of the Board of Directors for the approval of the turnover as of 30 September 2026 not subject to audit

Financial Calendar 2025



13/02/2025


Board of Directors

Meeting of the Board of Directors for the approval of the 2024 annual turnover not subject to audit



28/03/2025


Board of Directors

Board of Directors meeting to approve the draft financial statements as of December 31, 2024



29/04/2025


Shareholders' Meeting

First call for the Shareholders’ meeting to approve the financial statements as of December 31, 2024



30/04/2025


Shareholders' Meeting

Second call for the Shareholders’ meeting to approve the financial statements as of December 31, 2024



06/05/2025


Board of Directors

Meeting of the Board of Directors for the approval of the turnover as of 31 March 2025 not subject to audit



18/07/2025


Board of Directors

Meeting of the Board of Directors for the approval of the turnover as of 30 June 2025 not subject to audit



29/09/2025


Board of Directors

Board of Directors meeting to approve the semi-annual report as of June 30, 2025 voluntarily subjected to audit



06/11/2025


Board of Directors

Meeting of the Board of Directors for the approval of the turnover as of 30 September 2025 not subject to audit

Financial Calendar 2024



13/02/2024


Board of Directors

Meeting of the Board of Directors for the approval of the 2023 annual turnover not subject to audit



29/03/2024


Board of Directors

Board of Directors meeting to approve the draft financial statements as of December 31, 2023



29/04/2024


Shareholders’ Meeting

First call for the Shareholders’ meeting to approve the financial statements as of December 31, 2023



30/04/2024


Shareholders’ Meeting

Second call for the Shareholders’ meeting to approve the financial statements as of December 31, 2023



06/05/2024


Board of Directors

Meeting of the Board of Directors for the approval of the turnover as of 31 March 2024 not subject to audit



18/07/2024


Board of Directors

Meeting of the Board of Directors for the approval of the turnover as of 30 June 2024 not subject to audit



30/09/2024


Board of Directors

Board of Directors meeting to approve the semi-annual report as of June 30, 2024



04/11/2024


Board of Directors

Meeting of the Board of Directors for the approval of the turnover as of 30 September 2024 not subject to audit

Financial Calendar 2023



30/03/2024


Board of Directors

Board of Directors meeting to approve the draft financial statements as of December 31, 2022



27/04/2023


Shareholders’ Meeting

First call for the Shareholders’ meeting to approve the financial statements as of December 31, 2022



28/04/2023


Shareholders’ Meeting

Second call for the Shareholders’ meeting to approve the financial statements as of December 31, 2022



28/09/2023


Board of Directors

Board of Directors meeting to approve the semi-annual report as of June 30, 2023

Financial Calendar 2022



30/03/2022


Board of Directors

Board of Directors meeting to approve the draft financial statements as of December 31, 2021



28/04/2022


Shareholders’ Meeting

First call for the Shareholders’ meeting to approve the financial statements as of December 31, 2021



29/04/2022


Shareholders’ Meeting

Second call for the Shareholders’ meeting to approve the financial statements as of December 31, 2021



29/09/2022


Board of Directors

Board of Directors meeting to approve the semi-annual report as of June 30, 2022

Financial Calendar 2021



29/03/2021


Board of Directors

Board of Directors meeting to approve the draft financial statements as of December 31, 2020



29/04/2021


Shareholders’ Meeting

First call for the Shareholders’ meeting to approve the financial statements as of December 31, 2020



30/04/2021


Shareholders’ Meeting

Second call for the Shareholders’ meeting to approve the financial statements as of December 31, 2020



27/09/2021


Board of Directors

Board of Directors meeting to approve the semi-annual report as of June 30, 2021

Financial Calendar 2020



31/03/2020


Board of Directors

Board of Directors meeting to approve the draft financial statements as of December 31, 2019



29/04/2020


Shareholders’ Meeting

First call for the Shareholders’ meeting to approve the financial statements as of December 31, 2019



30/04/2020


Shareholders’ Meeting

Second call for the Shareholders’ meeting to approve the financial statements as of December 31, 2019



30/06/2020


Board of Directors

Board of Directors meeting to approve the semi-annual report as of June 30, 2020

⚠️ ATTENZIONE: ⚠️

Siamo venuti a conoscenza dell’esistenza del sito internet “terrabiomedical.com“, che riproduce fedelmente i contenuti e l’immagine del sito web ufficiale della nostra Società, senza alcuna nostra autorizzazione.

A tal proposito, Arterra Bioscience S.p.A. precisa di essere totalmente estranea al suddetto sito internet, così come a qualsiasi attività, iniziativa o comunicazione riconducibile a una società denominata “Terra North America” e/o alla Sig.ra “Natalia Astor”.

Per qualsiasi informazione, comunicazione o richiesta relativa ad Arterra Bioscience S.p.A., vi invitiamo a fare esclusivo riferimento ai nostri canali ufficiali, consultabili sul sito “www.arterrabio.it”.

Grazie per l’attenzione.

Arterra Bioscience S.p.A.

⚠️ IMPORTANT NOTICE: ⚠️

We have become aware of the existence of the website “terrabiomedical.com”, which reproduces the content and visual identity of our Company’s official website without our knowledge or authorization.

In this regard, Arterra Bioscience S.p.A. hereby states that it has absolutely no connection with the aforementioned website, nor with any activities, initiatives or communications attributable to an entity operating under the name “Terra North America” and/or Ms. “Natalia Astor”.

For any information, communications or enquiries concerning Arterra Bioscience S.p.A., please refer exclusively to our official communication channels, available on our website: “www.arterrabio.it”.

Thank you for your attention.

Arterra Bioscience S.p.A.